ClinTec Sees Rise in Revenues and Growth in the Middle East
ClinTec, a full service multinational contract research organisation (CRO), has today announced that it has achieved organic growth with a 45 per cent increase in global sales revenues over the last twelve months; expanded its client base and signing new contracts with 11 of the world’s top 25 pharmaceutical firms.
With a presence in some 40 countries around the world, ClinTec International manages clinical trials in all major therapeutic areas, including oncology, neurology, cardiovascular, respiratory as well as gastroenterology.
Dr. Rabinder Buttar, the company’s founder, President and CEO commented: “The launch of our Cairo office in October was one of the high points of the year. Apart from providing our global pharmaceutical associates with access to new patient populations, ClinTec Cairo cements our reputation as the major CRO in the Middle East and North Africa (MENA) region."
ClinTec has played a key role in 2009 in facilitating complex restructuring programmes for Global Pharma, who are searching for innovative ways to optimise their R&D efforts. The shift of research delivery from West to East is an area in which ClinTec is able to offer a credible solution for using a blend between flexible resource solutions and off-shore project delivery.
Driving Diversity with the Integrated Research Model
October 16th 2024Ashley Moultrie, CCRP, senior director, DEI & community engagement, Javara discusses current trends and challenges with achieving greater diversity in clinical trials, how integrated research organizations are bringing care directly to patients, and more.
AI in Clinical Trials: A Long, But Promising Road Ahead
May 29th 2024Stephen Pyke, chief clinical data and digital officer, Parexel, discusses how AI can be used in clinical trials to streamline operational processes, the importance of collaboration and data sharing in advancing the use of technology, and more.
The Rise of Predictive Engagement Tools in Clinical Trials
November 22nd 2024Patient attrition can be a significant barrier to the success of a randomized controlled trial (RCT). Today, with the help of AI-powered predictive engagement tools, clinical study managers are finding ways to proactively reduce attrition rates in RCTs, and increase the effectiveness of their trial. In this guide, we look at the role AI-powered patient engagement tools play in clinical research, from the problems they’re being used to solve to the areas and indications in which they’re being deployed.
